COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran-Reference-Cited by-同舟云学术

COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran

Published:2023-09-06 Issue:5 Volume:188 Page:783-792
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Abdorahimi Mahsa,Pakdel Farzad,Salehi Mohammadreza,Alcazar-Fuoli Laura,Hashemi Seyed Jamal,Daie Ghazvini Roshanak,Ahmadkhani Fardin,Ahmadikia Kazem,Abdollahi Alireza,Debran Juan Carlos Soto,Tabari Azin,Farrokh Fatemeh,Mousavand Atefeh,Afarinesh Khaki Pegah,Salami Khaneshan Arezoo,Ibrahim Ashraf S.,Khodavaisy Sadegh

Funder

Tehran University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscellaneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology

Link

https://link.springer.com/content/pdf/10.1007/s11046-023-00785-3.pdf

Reference39 articles.

1. Mishra Y, Prashar M, Sharma D, Kumar VP, Tilak T. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr. 2021;15(4):102196.

2. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, Savio J, Sethuraman N, Madan S, Shastri P. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerg Infect Dis. 2021;27(9):2349.

3. Arora R, Goel R, Khanam S, Kumar S, Shah S, Singh S, Chhabra M, Meher R, Khurana N, Sagar T. Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021–a preliminary report from a single hospital. Clin Ophthalmol (Auckland, NZ). 2021;15:3505.